Skip to Main Content

Author Details

Shuling Ren
Beijing Friendship Hospital, Capital Medical University
2013
38
22
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36912560Relative efficacy of prophylactic strategies for postthyroidectomy hypocalcemia: a systematic review and network meta-analysis.Int J Surg2023
35418150Retraction Note to: Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7.Stem Cell Res Ther2022
34134771Exosomal SNHG16 secreted by CSCs promotes glioma development via TLR7.Stem Cell Res Ther2021
33491747Reciprocal activation of HEY1 and NOTCH4 under SOX2 control promotes EMT in head and neck squamous cell carcinoma.Int J Oncol2021
34548317Extrachromosomal DNA in HPV-Mediated Oropharyngeal Cancer Drives Diverse Oncogene Transcription.Clin Cancer Res2021
34446736Efficient intracellular delivery of proteins by a multifunctional chimaeric peptide in vitro and in vivo.Nat Commun2021
32848210HPV E2, E4, E5 drive alternative carcinogenic pathways in HPV positive cancers.Oncogene2020
31778279miR-30e-5p represses angiogenesis and metastasis by directly targeting AEG-1 in squamous cell carcinoma of the head and neck.Cancer Sci2020
31721164A novel splice variant of LOXL2 promotes progression of human papillomavirus-negative head and neck squamous cell carcinoma.Cancer2020
32041482Targeting Viral DNA and Promoter Hypermethylation in Salivary Rinses for Recurrent HPV-Positive Oropharyngeal Cancer.Otolaryngol Head Neck Surg2020
31850594Rational genomic optimization of DNA detection for human papillomavirus type 16 in head and neck squamous cell carcinoma.Head Neck2020
30626753Variations in HPV function are associated with survival in squamous cell carcinoma.JCI Insight2019
31097695Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.Nat Commun2019
31142745Publisher Correction: Chromatin dysregulation and DNA methylation at transcription start sites associated with transcriptional repression in cancers.Nat Commun2019
31111621Wnt3a promotes radioresistance via autophagy in squamous cell carcinoma of the head and neck.J Cell Mol Med2019
30933315Mutation of chromatin regulators and focal hotspot alterations characterize human papillomavirus-positive oropharyngeal squamous cell carcinoma.Cancer2019
29146722The <i>NOTCH4</i>-<i>HEY1</i> Pathway Induces Epithelial-Mesenchymal Transition in Head and Neck Squamous Cell Carcinoma.Clin Cancer Res2018
29945995Characterization of Alternative Splicing Events in HPV-Negative Head and Neck Squamous Cell Carcinoma Identifies an Oncogenic DOCK5 Variant.Clin Cancer Res2018
30070359Discovery and development of differentially methylated regions in human papillomavirus-related oropharyngeal squamous cell carcinoma.Int J Cancer2018
28053597miR-324-3p suppresses migration and invasion by targeting WNT2B in nasopharyngeal carcinoma.Cancer Cell Int2017
28454443miR-185-3p regulates the invasion and metastasis of nasopharyngeal carcinoma by targeting WNT2B <i>in vitro</i>.Oncol Lett2017
28599416Autophagy inhibition impairs the epithelial-mesenchymal transition and enhances cisplatin sensitivity in nasopharyngeal carcinoma.Oncol Lett2017
27108809Ionizing radiation promotes advanced malignant traits in nasopharyngeal carcinoma via activation of epithelial-mesenchymal transition and the cancer stem cell phenotype.Oncol Rep2016
27599611Genome-wide analyses of long noncoding RNA expression profiles correlated with radioresistance in nasopharyngeal carcinoma via next-generation deep sequencing.BMC Cancer2016
27498905Next generation deep sequencing identified a novel lncRNA n375709 associated with paclitaxel resistance in nasopharyngeal carcinoma.Oncol Rep2016
25351620Ephrin typeâ¿¿A receptor 2 regulates sensitivity to paclitaxel in nasopharyngeal carcinoma via the phosphoinositide 3â¿¿kinase/Akt signalling pathway.Mol Med Rep2015
26788168Analysis of clinical features and prognosis of malignant triton tumor: A report of two cases and literature review.Oncol Lett2015
25674742Metadherin regulation of vascular endothelial growth factor expression is dependent upon the PI3K/Akt pathway in squamous cell carcinoma of the head and neck.Medicine (Baltimore)2015
25578493Increased expression of miR-93 is associated with poor prognosis in head and neck squamous cell carcinoma.Tumour Biol2015
24099913Metadherin regulates metastasis of squamous cell carcinoma of the head and neck via AKT signalling pathway-mediated epithelial-mesenchymal transition.Cancer Lett2014
25735100[The expression and significance of miRNA-324-3p and WNT2B in nasopharyngeal carcinoma].Lin Chuang Er Bi Yan Hou Tou Jing Wai Ke Za Zhi2014
25297925miR-185-3p regulates nasopharyngeal carcinoma radioresistance by targeting WNT2B in vitro.Cancer Sci2014
23364922Increased expression of metadherin protein predicts worse disease-free and overall survival in laryngeal squamous cell carcinoma.Int J Cancer2013
23583221MicroRNA-324-3p regulates nasopharyngeal carcinoma radioresistance by directly targeting WNT2B.Eur J Cancer2013
23755789[EphA2 mediated vascular endothelial growth factor expression via the p38 MAPK signaling pathway in squamous cell carcinoma of the head and neck].Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi2013
23710918[Expression of astrocyte elevated gene-1 protein and its clinical significance in laryngeal squamous cell carcinoma].Zhonghua Bing Li Xue Za Zhi2013
24195824[Irradiation induced epithelial-mesenchymal transition in nasopharyngeal carcinoma in vitro].Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi2013
24367666Genome-wide analyses of radioresistance-associated miRNA expression profile in nasopharyngeal carcinoma using next generation deep sequencing.PLoS One2013
  • 1 - 38 of 38

Recommended Authors

Jixi Li
People's Hospital of Henan University, Henan Provincial People's Hospital
Career Start Year 2018
Number of shared co-authors 0
Stefano Cavalieri
Fondazione IRCCS Istituto Nazionale dei Tumori di Milano, University of Milan
Career Start Year 2016
Number of shared co-authors 0
Hua Li
University of California san francisco
Career Start Year 2013
Number of shared co-authors 1
Mushfiq H Shaikh
University of Western Ontario
Career Start Year 2013
Number of shared co-authors 0
Stefan Hartmann
University Hospital Wurzburg
Career Start Year 2013
Number of shared co-authors 0
Farhad Ghasemi
Western University
Career Start Year 2012
Number of shared co-authors 0
Jeff P Bruce
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2010
Number of shared co-authors 0
Pinaki Bose
Cumming School of Medicine, University of Calgary
Career Start Year 2008
Number of shared co-authors 0
Farhoud Faraji
University of California San Diego Health
Career Start Year 2008
Number of shared co-authors 12
Myung Woul Han
Ulsan University Hospital, University of Ulsan College of Medicine
Career Start Year 2006
Number of shared co-authors 0
Shao Hui Huang
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 2004
Number of shared co-authors 2
Antonio L Amelio
University of North Carolina at Chapel Hill
Career Start Year 2004
Number of shared co-authors 1
Nadeem Riaz
Memorial Sloan Kettering Cancer Center
Career Start Year 2004
Number of shared co-authors 1
Sabrina Daniela da Silva
Jewish General Hospital
Career Start Year 2004
Number of shared co-authors 0
Nehad M Alajez
College of Health and Life Sciences, Hamad Bin Khalifa University, Qatar Foundation
Career Start Year 2004
Number of shared co-authors 0
Yongmei Song
Shandong University of Traditional Chinese Medicine
Career Start Year 2003
Number of shared co-authors 0
Wei Shi
Research Institute, Princess Margaret Cancer Centre
Career Start Year 2002
Number of shared co-authors 0
Natalia Issaeva
The University of North Carolina at Chapel Hill
Career Start Year 2002
Number of shared co-authors 1
Anthony C Nichols
University of Western Ontario
Career Start Year 2001
Number of shared co-authors 1
Loris De Cecco
Fondazione IRCCS Istituto Nazionale dei Tumori
Career Start Year 2000
Number of shared co-authors 0
Hyunseok Kang
Johns Hopkins University
Career Start Year 2000
Number of shared co-authors 8
Rifat Hasina
University of Chicago Medicine
Career Start Year 1999
Number of shared co-authors 0
David Neil Hayes
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 6
Lifang Yang
Cancer Research Institute, Central South University
Career Start Year 1998
Number of shared co-authors 0
Angela B Y Hui
Stanford University
Career Start Year 1996
Number of shared co-authors 0
Fei-Fei Liu
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 1
Jennifer R Grandis
University of California san francisco
Career Start Year 1988
Number of shared co-authors 12
Ravindra Uppaluri
Brigham and Women's Hospital
Career Start Year 1988
Number of shared co-authors 1
Wendell G Yarbrough
University of North Carolina at Chapel Hill
Career Start Year 1986
Number of shared co-authors 3
Ruud H Brakenhoff
Vrije Universiteit Amsterdam
Career Start Year 1986
Number of shared co-authors 1

Collaborators

Chao Liu
Xiangya Hospital, Central South University
Co-authored papers 24
Guo Li
Co-authored papers 22
Joseph A Califano
University of California
Co-authored papers 13
Theresa Guo
Moores Cancer Center, University of California
Co-authored papers 12
Akihiro Sakai
Tokai University
Co-authored papers 10
Mizuo Ando
University of Tokyo
Co-authored papers 10
Takahito Fukusumi
Osaka University Graduate School of Medicine
Co-authored papers 10
Kathleen M Fisch
Center for Computational Biology and Bioinformatics, University of California
Co-authored papers 8
Sayed Sadat
Moores Cancer Center, University of California San Diego
Co-authored papers 8
Guorong Xu
Chinese University of Hong Kong
Co-authored papers 7
Yuki Saito
Niigata Prefectural Tokamachi Hospital.
Co-authored papers 7
Sunny Haft
Moores Cancer Center, University of California
Co-authored papers 6
Alexander V Favorov
Johns Hopkins School of Medicine
Co-authored papers 5
Zubair Khan
University of Texas at Houston Health Science Center
Co-authored papers 5
John Pang
University of Washington
Co-authored papers 5
Daria A Gaykalova
Institute for Genome Sciences, University of Maryland School of Medicine
Co-authored papers 4
Elana J Fertig
Johns Hopkins University School of Medicine
Co-authored papers 4
Pablo Tamayo
University of California San Diego
Co-authored papers 3
Trey Ideker (CM4AI)
University of California San Diego
Co-authored papers 3
Jorge Silvio Gutkind
Moores Cancer Center, University of California San Diego
Co-authored papers 2
Srinivasan Yegnasubramanian
Johns Hopkins University School of Medicine
Co-authored papers 2
Patrick K Ha
University of California San Francisco
Co-authored papers 2
Minya Pu
University of California
Co-authored papers 2
Tatsuya Yamasoba
The University of Tokyo
Co-authored papers 2
Karen Messer
Herbert Wertheim School of Public Health, University of California San Diego
Co-authored papers 2
Kate Medetgul-Ernar
University of California San Diego Health Moores Cancer Center.
Co-authored papers 2
Nam Q Bui
University of California San Diego
Co-authored papers 1
Jennifer R Wang
The University of Texas MD Anderson Cancer Center
Co-authored papers 1
Mara Gilardi
Institute of Medical Genetics and Pathology.
Co-authored papers 1
Michael M Allevato
University of Michigan Medical School.
Co-authored papers 1
Release 1.2